Physician profile
Samina Ismail
NPI 1609849900
$2,116.92
in general payments reported to CMS, 2019-2025
17 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $480 · 2021: $595 · 2022: $308 · 2024: $471 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $387.54 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Vanda Pharmaceuticals INC. | $382.71 | 2021-2022 | |
| Lilly USA, LLC | $336.99 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $206.60 | 2021 | |
| Amgen INC. | $175.54 | 2019-2024 | Repatha, Otezla |
| Novo Nordisk INC | $108.39 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $97.46 | 2020-2022 | |
| Allergan, INC. | $78.87 | 2020 | |
| Glaxosmithkline, LLC. | $76.30 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $58.55 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.10 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $43.12 | 2021 | |
| Shire North American Group INC | $29.23 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.82 | 2019-2020 | |
| Dexcom, INC. | $26.88 | 2024 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.89 | 2020 | |
| Merck Sharp & Dohme LLC | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samina Ismail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.